SCPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - scPharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 5.67 USD Market Closed

Market Cap: $304.4m

	scPharmaceuticals Inc NASDAQ:SCPH	US
	Pantheon Resources PLC LSE:PANR	UK
	Do & Co AG IST:DOCO.E	AT
	SMN Corp TSE:6185	JP
	Acurx Pharmaceuticals Inc NASDAQ:ACXP	US

Profitability Summary

scPharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

70%

Declining Gross Margin

74% > 68%

Negative Operating Margin

-159%

Negative 3Y Average Operating Margin

-300%

Operating Margin is Increasing

-1 211% > -159%

Negative Net Margin

-184%

Negative 3Y Average Net Margin

-319%

Net Margin is Increasing

-1 210% > -184%

Negative Free Cash Flow Margin

-132%

Negative 3Y Average Free Cash Flow Margin

-316%

Free Cash Flow Margin is Increasing

-1 370% > -132%

Exceptional ROE

1 520%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-416%

ROIC is Increasing

-723% > -279%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.